Molecule EVRRF Stock
Molecule Price Chart
Molecule EVRRF Financial and Trading Overview
| Molecule stock price | 0.0025 USD |
| Previous Close | 0.0061 USD |
| Open | 0.0061 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0061 - 0.0061 USD |
| 52 Week Range | 0.0012 - 0.05 USD |
| Volume | 120 USD |
| Avg. Volume | 376 USD |
| Market Cap | 1.47M USD |
| Beta (5Y Monthly) | -0.935157 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
EVRRF Valuation Measures
| Enterprise Value | 5.71M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.69938076 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 2.721 |
| Enterprise Value/EBITDA | -1.911 |
Trading Information
Molecule Stock Price History
| Beta (5Y Monthly) | -0.935157 |
| 52-Week Change | -87.55% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.05 USD |
| 52 Week Low | 0.0012 USD |
| 50-Day Moving Average | 0.00532 USD |
| 200-Day Moving Average | 0.01 USD |
EVRRF Share Statistics
| Avg. Volume (3 month) | 376 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 97.78M |
| Float | 82.02M |
| Short Ratio | N/A |
| % Held by Insiders | 16.52% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | October 31, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | October 31, 2023 |
Profitability
| Profit Margin | -184.061% |
| Operating Margin (ttm) | -170.71% |
| Gross Margin | -48.75% |
| EBITDA Margin | -142.39% |
Management Effectiveness
| Return on Assets (ttm) | -51.92% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 2.1M USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | 50.60% |
| Gross Profit (ttm) | N/A |
| EBITDA | -2990110 USD |
| Net Income Avi to Common (ttm) | -3865107 USD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 533 USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 5.12M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.14 |
| Book Value Per Share (mrq) | -0.044 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -439773 USD |
| Levered Free Cash Flow (ttm) | 419.12K USD |
Profile of Molecule
| Country | United States |
| State | ON |
| City | Lansdowne |
| Address | 591 Reynolds Road |
| ZIP | K0E 1L0 |
| Phone | N/A |
| Website | https://molecule.ca |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It also offers cannabis extracts, beverages, edibles, and topical products directly to provincial retailers. The company offers its beverage products under the PHRESH, KLÕN, EMBODY, and CANAJO brands. Molecule Holdings Inc. is based in Lansdowne, Canada.
Q&A For Molecule Stock
What is a current EVRRF stock price?
Molecule EVRRF stock price today per share is 0.0025 USD.
How to purchase Molecule stock?
You can buy EVRRF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Molecule?
The stock symbol or ticker of Molecule is EVRRF.
Which industry does the Molecule company belong to?
The Molecule industry is Drug Manufacturers-Specialty & Generic.
How many shares does Molecule have in circulation?
The max supply of Molecule shares is 250.45M.
What is Molecule Price to Earnings Ratio (PE Ratio)?
Molecule PE Ratio is now.
What was Molecule earnings per share over the trailing 12 months (TTM)?
Molecule EPS is -0.03 USD over the trailing 12 months.
Which sector does the Molecule company belong to?
The Molecule sector is Healthcare.